This inventor holds 18 USPTO granted patents. Top assignees: Novartis Ag, Imperial Chemical Industries Limited, Degussa Aktiengesellschaft. Active years: 1986-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zürich, CH (2001 - 2002)
- Zurich, CH (1986 - 2003)
Company Filing History:
6 out of 3,975 
4 out of 3,840 
3 out of 1,694 
Years Active: 1986-2003
Title: Dieter Seebach: Innovator in Peptide Chemistry
Introduction
Dieter Seebach is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of peptide chemistry, holding a total of 18 patents. His work has had a profound impact on various applications in polymer science and catalysis.
Latest Patents
Among his latest patents, Seebach has developed TADDOL and titanium taddolate dendrimers. These dendrimers are described for their use as crosslinkers in polymerization reactions. Additionally, the use of titanium salts of polymer-bound TADDOL dendrimers as catalysts in enantioselective addition reactions is disclosed in his patents.
Career Highlights
Throughout his career, Dieter Seebach has worked with notable companies such as Novartis AG and Imperial Chemical Industries Limited. His expertise in peptide chemistry has positioned him as a leader in his field, contributing to advancements in both academic and industrial settings.
Collaborations
Seebach has collaborated with esteemed colleagues, including Soo Young Ko and Hans Kobel. These partnerships have further enriched his research and innovation efforts.
Conclusion
Dieter Seebach's contributions to peptide chemistry and his innovative patents highlight his role as a key figure in the scientific community. His work continues to influence advancements in polymer science and catalysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile